| RS865912479 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS865913887 |
ADCY10
|
Health Risk |
Pathogenic |
— |
| RS865920726 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS865921466 |
MYPN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1KK, Melanoma |
| RS865922330 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS865930770 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS865931042 |
CHST3
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS865939646 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS865947251 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Thromboembolism |
| RS865951519 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS865969846 |
CLCN7
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS865973286 |
SLC12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS865974846 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS865977487 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, RPGR-related retinopathy |
| RS865981027 |
C7
|
Health Risk |
Pathogenic |
— |
| RS865985076 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS865985297 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS865990202 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 19, Retinal dystrophy |
| RS865990681 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS865994024 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS865996246 |
VSIG10L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS865999256 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS866001342 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS866002450 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS866005910 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS866005940 |
FANCE
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS866011766 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS866012140 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS866020952 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS866021264 |
CTSC
|
Health Risk |
Likely pathogenic |
Haim-Munk syndrome, Periodontitis |
| RS866033169 |
ASNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS866035312 |
ATP13A2
|
Health Risk |
Pathogenic |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS866037100 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 69 |
| RS866037881 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS866044092 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Huntington disease-like syndrome, Alzheimer disease 4 |
| RS866046915 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Medulloblastoma |
| RS866050664 |
ASCC1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy with congenital bone fractures 2, Centronuclear myopathy |
| RS866054011 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS866055625 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS866055657 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Familial cold autoinflammatory syndrome 2 |
| RS866061439 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS866067386 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS866069044 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS866069095 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS866069972 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS866072933 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS866075757 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease, 7 conditions |
| RS866087553 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS866096259 |
CFAP44
|
Health Risk |
Pathogenic |
Spermatogenic failure 20, CFAP44-related disorder |
| RS866097920 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS866101707 |
VCP
|
Health Risk |
Likely pathogenic |
Alzheimer disease, Alzheimer disease |
| RS866101912 |
FAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Karyomegalic interstitial nephritis, Karyomegalic interstitial nephritis |
| RS866104898 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder 1 |
| RS866122374 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS866130958 |
C2
|
Health Risk |
Pathogenic |
— |
| RS866130991 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS866138115 |
HBG2
|
Health Risk |
Pathogenic |
Hereditary persistence of fetal hemoglobin, Hereditary persistence of fetal hemoglobin |
| RS866140272 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS866144313 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS866146696 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS866151033 |
ITGA6
|
Health Risk |
Pathogenic |
— |
| RS866158774 |
MIPEP
|
Health Risk |
Pathogenic/Likely pathogenic |
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome, Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome |
| RS866163858 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS866179648 |
DDX41
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, DDX41-related hematologic malignancy predisposition syndrome |
| RS866182415 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS866183824 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS866184460 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS866186589 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS866191653 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS866199775 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS866218814 |
ETFA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS866225395 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS866226288 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS866229566 |
TGM1
|
Health Risk |
Pathogenic |
— |
| RS866231149 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS866231304 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS866237249 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS866240607 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS866242352 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
— |
| RS866242631 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS866257451 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS866260025 |
PFKM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type VII |
| RS866260675 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS866262581 |
SETD1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with seizures and language delay, Inborn genetic diseases |
| RS866266558 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS866273473 |
SMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS866273848 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS866277517 |
MNX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Currarino triad, Currarino triad |
| RS866282352 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS866283042 |
CACNA2D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Developmental and epileptic encephalopathy 110 |
| RS866288154 |
LARP7
|
Health Risk |
Pathogenic |
LARP7-related disorder, LARP7-related disorder |
| RS866290641 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS866290802 |
CDH3
|
Health Risk |
Pathogenic |
Hypotrichosis, Hypotrichosis |
| RS866294686 |
TRIM8
|
Health Risk |
Pathogenic/Likely pathogenic |
TRIM8-related epileptic encephalopathy, Focal segmental glomerulosclerosis and neurodevelopmental syndrome |
| RS866298268 |
PUS1
|
Health Risk |
Pathogenic |
— |
| RS866300270 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS866302515 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS866309952 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS866311790 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS866313799 |
AMER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |